Chardan Capital Estimates Tourmaline Bio FY2025 Earnings
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Stock analysts at Chardan Capital issued their FY2025 earnings estimates for shares of Tourmaline Bio in a report issued on Wednesday, April 23rd. Chardan Capital analyst D. Gataulin anticipates that the company will post earnings per share of ($4.10) for the year. Chardan Capital currently has a […]
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Stock analysts at Chardan Capital issued their FY2025 earnings estimates for shares of Tourmaline Bio in a report issued on Wednesday, April 23rd. Chardan Capital analyst D. Gataulin anticipates that the company will post earnings per share of ($4.10) for the year. Chardan Capital currently has a […]
